CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest of -$530.00 thousand for the 12-month period ending 2015-12-26, per its 10-K filed 2016-02-12.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest · last filed 2016-02-12
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for fiscal 2015 was -$530.00K, a 105.36% decline from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for fiscal 2014 was $9.90M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for fiscal 2013 was -$7.80M.
| Period end | Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2015-12-26 | -$530.00K 10-K · filed 2016-02-12 |
| 2014-12-27 | $9.90M 10-K · filed 2016-02-12 |
| 2013-12-28 | -$7.80M 10-K · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |